Argenx Se (ARGX) EPS (Basic) (2016 - 2026)
Argenx Se (ARGX) posted EPS (Basic) of $5.9 for Q1 2026, down 32.17% on a QoQ basis from $8.69 in Q4 2025, and up 112.82% year-over-year from $2.77 in Q1 2025.
Argenx Se (ARGX) EPS (Basic) (2016 - 2026) Analysis & Trends
Argenx Se's EPS (Basic) history runs 11 years deep, the most recent figure standing at $5.9 for Q1 2026.
- Quarterly EPS (Basic) rose 112.82% year-over-year to $5.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.99 (up 37.53% YoY) and the FY2025 annual result came in at $21.08, up 51.46% from the prior year.
- EPS (Basic) was $5.9 for Q1 2026 at Argenx Se, down from $8.69 in the prior quarter.
- Across five years, EPS (Basic) topped out at $12.93 in Q4 2024 and bottomed at -$4.36 in Q1 2022.
- A 5-year average of $2.26 and a median of $0.49 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 438.82% — and 2024, when it soared 845.59%.
- Argenx Se's EPS (Basic) stood at -$0.71 in 2022, then sank by 144.31% to -$1.73 in 2023, then jumped by 845.59% to $12.93 in 2024, then sank by 32.77% to $8.69 in 2025, then tumbled by 32.17% to $5.9 in 2026.
- Business Quant data shows ARGX's EPS (Basic) at $5.9 in Q1 2026, $8.69 in Q4 2025, and $5.61 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | 8.69 |
| Sep 30, 2025 | 5.61 |
| Jun 30, 2025 | 4.02 |
| Mar 31, 2025 | 2.77 |
| Dec 31, 2024 | 12.93 |
| Sep 30, 2024 | 1.52 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | -1.04 |
| Dec 31, 2023 | -1.73 |
| Sep 30, 2023 | -1.25 |
| Jun 30, 2023 | -1.69 |
| Mar 31, 2023 | -0.52 |
| Dec 31, 2022 | -0.71 |
| Sep 30, 2022 | -4.26 |
| Jun 30, 2022 | 12.10 |
| Mar 31, 2022 | -4.36 |
| Dec 31, 2021 | -4.66 |
| Sep 30, 2021 | -4.54 |
| Jun 30, 2021 | 2.05 |